Extracorporeal membrane oxygenation in the newborn and beyond
- PMID: 3061700
Extracorporeal membrane oxygenation in the newborn and beyond
Abstract
Extracorporeal membrane oxygenation (ECMO) has gained notoriety recently as a treatment of last resort for neonates at term or near term who suffer from pulmonary failure. Because of serious inherent risks, the procedure is at present reserved for infants with reversible pulmonary disease who have failed conventional or high-frequency ventilation and who meet the prognostic criterion of 80 percent mortality.
Similar articles
-
Survival of infants with persistent pulmonary hypertension without extracorporeal membrane oxygenation.Pediatrics. 1989 Jul;84(1):1-6. Pediatrics. 1989. PMID: 2740158
-
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study.Pediatrics. 1989 Dec;84(6):957-63. Pediatrics. 1989. PMID: 2685740 Clinical Trial.
-
[Congenital diaphragmatic hernia: an analysis of the results and prognostic factors prior to the development of an ECMO program].An Esp Pediatr. 1996 Jun;44(6):568-72. An Esp Pediatr. 1996. PMID: 8849100 Spanish.
-
Extracorporeal membrane oxygenation for perinatal and pediatric patients.Respir Care. 2003 Apr;48(4):352-62; discussion 363-6. Respir Care. 2003. PMID: 12667264 Review.
-
Respiratory failure and extracorporeal membrane oxygenation.Semin Pediatr Surg. 2008 Feb;17(1):34-41. doi: 10.1053/j.sempedsurg.2007.10.006. Semin Pediatr Surg. 2008. PMID: 18158140 Review.
Cited by
-
Increased parathyroid hormone and decreased calcitriol during neonatal extracorporeal membrane oxygenation.Intensive Care Med. 2005 Feb;31(2):264-70. doi: 10.1007/s00134-004-2543-7. Epub 2005 Feb 1. Intensive Care Med. 2005. PMID: 15685444